BJDX Bluejay Diagnostics announces successful completion of enrollment in the symon-ii multicenter clinical validation study Bluejay Diagnos

BJDX Bluejay Diagnostics announces successful completion of enrollment in the symon-ii multicenter clinical validation study Bluejay Diagnostics - preliminary symon-ii data show 17% 28-day mortality rate